| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 |
| filingDate |
1996-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26f89411a1950c4b3af6c7fcd1f95de1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_366aeba27e72741096d3e44430a689a4 |
| publicationDate |
1998-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5789444-A |
| titleOfInvention |
Method of reducing glutamate neurotoxicity with anthranilic acid derivatives |
| abstract |
A method of reducing neurotoxic injury due to acute or chronic neurological insults by administering an anthranilic acid derivative is disclosed. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003185754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415393-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003166554-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010069494-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004147590-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007088074-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6620850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2134323-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2134323-A1 |
| priorityDate |
1995-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |